ArticleBiophotonics discovery2026
Machine-learning-based tumor segmentation and classification using dynamic optical contrast imaging for thyroid cancer.
Article in Biophotonics discovery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Significance: Thyroid cancer is the most common endocrine malignancy, and diagnosis is often challenging due to overlapping features between benign and malignant nodules. Fine-needle aspiration, the clinical gold standard, frequently yields indeterminate results and lacks spatial context, leading to unnecessary surgeries. Real-time margin assessment also remains limited. There is a need for accurate, label-free, spatially resolved imaging. Dynamic optical contrast imaging (DOCI), which measures autofluorescence lifetimes of endogenous fluorophores, offers a promising platform for intraoperative cancer detection. Aim: We develop and evaluate a machine learning integrated DOCI framework to classify thyroid tissue subtypes and segment cancerous regions from Approach: Fresh Results: The first two PCA components explained over 70% of spectral variance and yielded well-separated tissue clusters. The regional PCA classifier achieved 92.3% validation accuracy and 100% accuracy on the test set. Full 23-channel U-Net models delivered strong segmentation (papillary: Dice nonempty 0.829, balanced Dice 0.914; follicular: Dice nonempty 0.618, balanced Dice 0.809). Reduced-channel models preserved most performance and improved follicular segmentation (Dice nonempty 0.762), confirming spectral redundancy. Conclusions: Integrating DOCI with interpretable machine learning enables accurate, label-free differentiation and segmentation of thyroid tissues. Channel reduction demonstrates that high performance is achievable with a compact spectral subset, supporting faster, more cost-efficient DOCI systems and future real-time intraoperative deployment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.